Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,599 public trials 548 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Active, Not Recruiting

Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone

NCT04392037

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • NWZ Alkmaar, Netherlands
  • Amsterdam UMC, location AMC Amsterdam, Netherlands
  • Amsterdam UMC, location VUmc Amsterdam, Netherlands
  • Rijnstate Arnhem, Netherlands
View Trial Details
Active, Not Recruiting

Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients

NCT04717700

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Aalborg University Hospital Aalborg, Denmark
  • Sydvestjysk Sygehus Esbjerg Esbjerg, Denmark
  • Regionshospitalet Gødstrup Gødstrup, Denmark
  • Odense University Hospital Odense, Denmark
View Trial Details
Active, Not Recruiting

A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone)

NCT04965155

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • AOU Ospedali Riuniti Umberto I Ancona, Italy
  • AOU Policlinico di Bari Bari, Italy
  • AOU di Bologna Bologna, Italy
  • Ospedale di Bolzano - Azienda Sanitaria dell'Alto Adige Bolzano, Italy
View all 14 locations
View Trial Details
Active, Not Recruiting

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

NCT04072458

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +40 more
Locations
  • Georgia Cancer Center Augusta, Georgia, United States
  • New York Medical College / Westchester Medical Center Valhalla, New York, United States
  • Sarah Cannon Research Institute/Tennesee Oncology Nashville, Tennessee, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT04939142

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The First Affiliated Hospital OF USTC Hefei, Anhui, China
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Chao-Yang Hospital Beijing, Beijing Municipality, China
View all 33 locations
View Trial Details
Active, Not Recruiting

A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant

NCT04096066

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • AO "SS. Antonio e Biagio" Alessandria, Italy
  • AOU Ospedali Riuniti Umberto I Ancona, Italy
  • Ospedale Mazzoni Ascoli Piceno, Italy
  • Policlinico di Bari Bari, Italy
View all 40 locations
View Trial Details
Active, Not Recruiting

A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM

NCT04786028

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Nova Scotia Health - QEII Health Sciences Centre Halifax, Nova Scotia, Canada
  • Hamilton Health Sciences Centre Hamilton, Ontario, Canada
  • The Ottawa Hospital General Campus Ottawa, Ontario, Canada
View Trial Details

Related conditions